Study allows establishing a timeline of obesity

September 27, 2017

Over the past decade, when investigating the factors associated with the growing epidemic of obesity in the world, scientists have identified two events that greatly contribute to weight gain.

One of them is the alteration in the profile of bacteria that make up the intestinal flora. Studies published from 2005 to 2007 showed that obese people generally present a set of microorganisms that stimulate the absorption of nutrients from food. That means an apple can be more fattening to an obese person than to a lean person. But we still do not know for sure whether this is the cause or the consequence of being overweight.

Another important occurrence is the death of a group of neurons found in a region of the brain called the hypothalamus. Known as POMC neurons, these cells function as nutrient sensors that tell the body that it is time to stop eating and that there is enough energy to expend. Studies have shown that after the loss of these sensors, individuals increasingly feel the need to ingest foods rich in fat and sugar. Conversely, their metabolism slows down and they store most of the energy provided by the unbalanced diet.

"We began to ask ourselves: what comes first? The change in the patient's eating patterns caused by an error in the system of the brain that controls hunger, or a change in the intestinal microbiome? Our most recent data suggest that the hypothalamus is damaged well before changes occur in the intestine," said Licio Augusto Velloso, coordinator of the Obesity and Comorbidities Research Center at the University of Campinas (UNICAMP) in Brazil, Sao Paulo state, one of the Research, Innovation and Dissemination Centers (RIDCs) funded by the Sao Paulo Research Foundation - FAPESP.

In a talk given in Lincoln, Nebraska, on September 19, during FAPESP Week Nebraska-Texas, Velloso presented the findings of a study carried out at the School of Medical Sciences (FCM) at UNICAMP during the postdoctoral studies of Daniela Razolli.

The group conducted a time-series analysis of the tissues of mice fed a diet rich in saturated fats - which lasted a total of four months, enough time for the animal to become obese. At various points throughout the experiment, a portion of the colony was sacrificed so that the researchers could analyze the brains and intestines.

"We began to detect hypothalamic alterations on the very first day of the obesogenic diet. But it took about two to three weeks for changes in the intestinal microbiota to appear. This is a relatively big time difference, considering that they are mice," Velloso explained.

In previous studies, the group from UNICAMP had described how damage to the POMC neurons occurred. The molecules of saturated fat ingested are absorbed by the intestine, enter the bloodstream and reach the brain together with the other nutrients in the food.

In the central nervous system, a defense cell known as microglia understand that the excess fat constitutes a threat to the neurons and begins to produce inflammatory molecules as if it were combating a pathogen.

"Initially, the inflammation undermines the proper functioning of the hypothalamic neurons. If this goes on for too long, the cells end up dying. This is probably the reason why individuals who have been obese for a long time have trouble losing weight and keeping weight off after various treatments. These individuals are simply no longer able to achieve balance in the flow of energy in the body," Velloso said.

As the experiment with mice showed, the neuronal damage starts well before the individual begins to gain weight, but can be reversed early in the process. If the inadequate diet persists, said Velloso, injury to the neuron becomes irreversible.

"If an individual has a meal rich in saturated fats, but then spends several days ingesting a high-fiber diet supplemented by vegetables, the inflammation in the hypothalamus diminishes and the neurons recover. What cannot happen is that the obesogenic diet becomes more frequent because it will lead to a gradual increase in the inflammatory process," the researcher said.

An unbalanced diet changes a series of metabolic parameters, promoting the development of diabetes and hypertension. In this context, said Velloso, the change in intestinal microbiota emerges, which in turn contributes to aggravating obesity as well as the diseases associated with it.

According to Velloso, studies by other groups have shown that a diet rich in simple carbohydrates such as those in sugar and white flour, can also increase lipid levels in the blood and indirectly promote inflammation in the hypothalamus.

"When comparing the two types of diets, however, the researchers concluded that the results are worse when there is excessive consumption of saturated fat," Velloso said.

The leading source of saturated fat in the human diet are foods of animal origin such as fatty meats, butter and dairy products. But that nutrient is also found in oil and by-products of coconut and in palm oil as well as in various processed foods such as cookies, ice cream, cakes and pies.


According to Velloso, recent studies suggest that it is possible to promote neurogenesis in the hypothalamus, in other words, stimulate the emergence of new POMC neurons in an attempt to fight obesity. But for now, this has only been tested in experiments with laboratory rodents. Much more research is needed to understand how the process of cell differentiation can be controlled.

"We are currently at the stage where we understand how the neural precursor cells, a type of stem cell found in the brain, function. We need to determine which factors have to be activated to trigger the process of neurogenesis. It is a first step, but may end up being a therapeutic solution to obesity in the future," Velloso said.

Producing food to promote health

FAPESP Week Nebraska-Texas, held September 18-22, is intended to promote collaboration among scientists from Brazil and the United States.

On this Tuesday morning, shortly before the presentation by Velloso, U.S. researcher Andrew Benson gave an overview of the Nebraska Food for Health Center , established nearly a year ago for the purpose of developing foods with proven health benefits, particularly those that effect the intestinal microbiome.

"Our food production system is currently concerned about such things as reducing costs, increasing productivity, and using resources more efficiently. But health concerns appear only with respect to safety. In other words, the system is more concerned about not killing people than it is about promoting health. We need a new paradigm," Benson said.

The idea, according to the researcher, is to study the genetic diversity of local crops, particularly soybeans, beans and other grains, in order to identify components found in these foods that are capable of beneficially influencing the profile of intestinal bacteria. In the future, the most promising compounds may be isolated and added to other types of processed foods.

In Benson's view, this approach can help fight metabolic, autoimmune, and cardiovascular diseases as well as cancer, intestinal bowel diseases and even neurological and lung diseases.

"We have a plan for the next 10 years. In the first five years, we will focus on our local crops and diseases. Then in the next five, we will approach the problem in a more comprehensive manner, and for that will need international partners," he emphasized.
The FAPESP Week Nebraska-Texas was held between 18-22 September, with the aim of fostering collaboration among Brazilian and American researchers. Supported by FAPESP, researchers from Sao Paulo State's higher-education institutions working on diverse areas presented their projects in Lincoln (Nebraska, USA) during September 18/19 and also in Lubbock (Texas, USA) during September 21/22. In each event, Brazilian scientists were able to strengthen bonds and gather knowledge from research projects presented by fellows from the University of Nebraska-Lincoln and Texas Tech University.

About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. For more information:

Fundação de Amparo à Pesquisa do Estado de São Paulo

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to